| Product Code: ETC9388027 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Oncology Molecular Diagnostic Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Oncology Molecular Diagnostic Market - Industry Life Cycle |
3.4 South Africa Oncology Molecular Diagnostic Market - Porter's Five Forces |
3.5 South Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 South Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F |
3.8 South Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 South Africa Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Africa Oncology Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in South Africa |
4.2.2 Technological advancements in molecular diagnostics |
4.2.3 Growing demand for personalized medicine in oncology |
4.3 Market Restraints |
4.3.1 High cost associated with molecular diagnostic tests |
4.3.2 Limited access to advanced healthcare facilities in certain regions of South Africa |
4.3.3 Regulatory challenges and compliance requirements |
5 South Africa Oncology Molecular Diagnostic Market Trends |
6 South Africa Oncology Molecular Diagnostic Market, By Types |
6.1 South Africa Oncology Molecular Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.5 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.1.8 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.9 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Africa Oncology Molecular Diagnostic Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.3 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2.4 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Africa Oncology Molecular Diagnostic Market, By Test Location |
6.3.1 Overview and Analysis |
6.3.2 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.3 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Other Establishments, 2021- 2031F |
6.3.4 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Point of Care, 2021- 2031F |
6.4 South Africa Oncology Molecular Diagnostic Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By PCR, 2021- 2031F |
6.4.3 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Multiplex, 2021- 2031F |
6.4.4 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.5 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.4.6 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021- 2031F |
6.4.7 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Chips and Microarrays, 2021- 2031F |
6.4.8 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.5 South Africa Oncology Molecular Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 South Africa Oncology Molecular Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
7 South Africa Oncology Molecular Diagnostic Market Import-Export Trade Statistics |
7.1 South Africa Oncology Molecular Diagnostic Market Export to Major Countries |
7.2 South Africa Oncology Molecular Diagnostic Market Imports from Major Countries |
8 South Africa Oncology Molecular Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostic technologies in oncology practices |
8.2 Number of partnerships and collaborations between diagnostic companies and healthcare providers |
8.3 Rate of reimbursement for molecular diagnostic tests in the oncology market |
9 South Africa Oncology Molecular Diagnostic Market - Opportunity Assessment |
9.1 South Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 South Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F |
9.4 South Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 South Africa Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Africa Oncology Molecular Diagnostic Market - Competitive Landscape |
10.1 South Africa Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 South Africa Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here